Oxford Nanopore Technologies (ONT) Stock Forecast & Price Target

GBX 125.40 -0.40 (-0.32%)

(As of 07:11 AM ET)

Oxford Nanopore Technologies - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy

Based on 5 Analyst Ratings

Sell
0

Hold
0

Buy
5

Based on 5 Wall Street analysts who have issued ratings for Oxford Nanopore Technologies in the last 12 months, the stock has a consensus rating of "Buy." Out of the 5 analysts, 5 have given a buy rating for ONT.

Consensus Price Target

GBX 235.50

According to the 5 analysts' twelve-month price targets for Oxford Nanopore Technologies, the average price target is GBX 235.50. The highest price target for ONT is GBX 282, while the lowest price target for ONT is GBX 190. The average price target represents a forecasted upside of 87.80% from the current price of GBX 125.40.

Get the Latest News and Ratings for ONT and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oxford Nanopore Technologies and its competitors.

ONT Analyst Ratings Over Time

Type	Current Forecast 11/21/23 to 11/20/24	1 Month Ago 10/22/23 to 10/21/24	3 Months Ago 8/23/23 to 8/22/24	1 Year Ago 11/21/22 to 11/21/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	GBX 235.50	GBX 235.50	GBX 276.75	GBX 392.80
Consensus Rating	Buy	Buy	Buy	Buy

Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.

ONT Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ONT Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oxford Nanopore Technologies Stock vs. The Competition

Type	Oxford Nanopore Technologies	Medical Companies
Consensus Rating Score	3.00	2.80
Consensus Rating	Buy	Moderate Buy
News Sentiment Rating	Positive News See Recent ONT News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
9/4/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars	Reiterated Rating	Buy	GBX 190	+39.40%
9/3/2024	Berenberg Bank 2 of 5 stars	Reiterated Rating	Buy	GBX 282	+115.93%
6/28/2024	Royal Bank of Canada 4 of 5 stars	Reiterated Rating	Outperform	GBX 260	+175.42%
5/23/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight
4/12/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	GBX 210	+96.26%
9/7/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight	GBX 355	+68.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 07:36 AM ET.

ONT Forecast - Frequently Asked Questions

: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Oxford Nanopore Technologies is GBX 235.50, with a high forecast of GBX 282 and a low forecast of GBX 190.
: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford Nanopore Technologies in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ONT shares.
: According to analysts, Oxford Nanopore Technologies's stock has a predicted upside of 87.80% based on their 12-month stock forecasts.
: Oxford Nanopore Technologies has been rated by research analysts at Berenberg Bank, and Deutsche Bank Aktiengesellschaft in the past 90 days.
: Analysts like Oxford Nanopore Technologies more than other "medical" companies. The consensus rating for Oxford Nanopore Technologies is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how ONT compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

This page (LON:ONT) was last updated on 11/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oxford Nanopore Technologies (ONT) Stock Forecast & Price Target